Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News

A Blood Test for Colon Cancer Screening? Not So Fast!

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

Both Sides of the Bars: Jail Reform as Mental Health Policy

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.

All Quiet on the Vaccine Front?

While public support for vaccines remains strong, quieter efforts to weaken vaccine policy, compensation programs, and scientific oversight are gaining ground. Here's what physicians need to know.

To Treat or Not to Treat? The COVID Conundrum

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

The Challenge With Health Data Is Using It Well

An international survey finds physicians are ready to use wearable health data. The bigger challenge is building the systems to turn that information into better care.

Sickle Cell Disease Linked to Higher Postpartum LARC Use

People with sickle cell disease received immediate postpartum long-acting reversible contraception at more than three times the rate of those without the condition, even after adjusting for clinical and demographic factors.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.

While public support for vaccines remains strong, quieter efforts to weaken vaccine policy, compensation programs, and scientific oversight are gaining ground. Here's what physicians need to know.

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

An international survey finds physicians are ready to use wearable health data. The bigger challenge is building the systems to turn that information into better care.

People with sickle cell disease received immediate postpartum long-acting reversible contraception at more than three times the rate of those without the condition, even after adjusting for clinical and demographic factors.

News All Time

Focal Therapy Shows Favorable Long-Term Outcomes

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

Parental Anxiety Persists Up to 2 Years After NICU Discharge

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Noncardia Gastric Cancer Risk Higher in Some Ethnic Groups

Hispanic and Asian populations in the US show a clinically meaningful risk for noncardia gastric cancer up to two decades earlier than non-Hispanic White populations.

Holmium Enucleation Safe for Recurrent Prostatic Obstruction

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

High Suspicion for Cyclosporiasis Needed, Tracing Continues

With the outlines shifting in the current outbreak, testing for the parasite is a no-brainer, say experts.

Fecal Biomarkers Distinguish Pediatric IBD From Diarrhea

Fecal eosinophil-derived neurotoxin, lipocalin-2, and calprotectin are elevated in pediatric IBD, with calprotectin best distinguishing IBD from acute diarrhea, a recent study shows.

First Evidence That Targeting Tau May Slow Cognitive Decline

The investigational drug diranersen led to tau reduction with the lowest dose showing the most consistently positive clinical effect.

Health Disparities and Access Barriers in GAD Care

Matthew Macaluso, DO, comments on systemic barriers that delay GAD diagnosis, highlighting the need for better access to psychiatric care and integrated treatment pathways.

Lecanemab for AD Shows Sustained Benefit in Real-World Study

Real-world data suggest lecanemab’s safety and efficacy mirror results from the pivotal Clarity AD trial and highlight the growing use of blood-based biomarkers in clinical practice.

Chemo Tied to Longer Survival After Pelvic Exenteration

A retrospective international study suggests adjuvant chemotherapy is associated with longer survival after pelvic exenteration in patients with high-risk gynecologic cancers.

When the Algorithm Knows the Risk but Misses the Fear

AI may flag low clinical risk, but it can still miss the patient’s fear, story, and lived experience.

THC-CBD Combination Reduces Agitation in Advanced Dementia

In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.

Adults Maltreated During Childhood Face Higher Disease Risk

Abuse or neglect during childhood is associated with increased risks for chronic physical and mental health conditions during adulthood, a study finds.

Freezing of Gait in Parkinson’s: What’s Beyond Medication?

A conference review highlights how combining cognitive, motor, and sensory training with cueing strategies may improve freezing of gait in Parkinson’s disease.

What the Fourth Year of Med School Is Really Like

Fourth-year med students are in for a lot of stress, anxiety, and expense, just not from studying.

Recommended News For You

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.

Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.

Novel Psychedelic Promising on Resistant Depression

Recommended Articles For You

Hematopoietic Aging Signatures and Future Hematologic Disease Risk 

Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions 

Iron Chelation Therapy: Preventing Long-Term Treatment Toxicities 

Modern Applications in Oncology in the Digital Era 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

2.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

3.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

4.

Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?

5.

Liquid Biopsies Cut EBV Burkitt Lymphoma Time to Diagnosis

1.

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies

2.

The Pros and Cons of Using Cyclophosphamide in Cancer Treatment 

3.

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies

4.

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape

5.

Iron Homeostasis Throughout the Female Lifespan

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

5.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot